Form 4: Hartford Great Health Corp.: Former CEO Rose Wang Hong Reports Transaction and Resignation

Sentiment:

SEC Form 4 Filing


Rose Wang Hong, former CEO and Director of Hartford Great Health Corp., reports a transaction involving common stock and her resignation effective April 1, 2024.

Summary

  • Rose Wang Hong, formerly the CEO and a Director of Hartford Great Health Corp. (HFUS), filed a Form 4.
  • The report details a transaction on March 19, 2024, involving common stock.
  • 2,940,000 shares were acquired at a price of $0.02.
  • 3,664,000 shares were disposed of.
  • Effective April 1, 2024, Rose Wang Hong resigned from her positions as CEO and Director.

Sentiment

Score: 5

Explanation: The document primarily reports a change in leadership and a stock transaction, which are neutral events. The sentiment is therefore considered neutral.

Industry Context

This announcement reflects a change in leadership at Hartford Great Health Corp., which may be of interest to investors and industry observers. The stock transaction may also be relevant to shareholders.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
CEORose Wang Hong04/01/2024Resignation
DirectorRose Wang Hong04/01/2024Resignation

Stakeholder Impact

  • Shareholders may be interested in the change in leadership and the stock transaction.
  • Employees may be affected by the change in leadership.

Key Dates

DateDescription
03/19/2024Date of common stock transaction.
04/01/2024Effective date of Rose Wang Hong's resignation as CEO and Director.
04/04/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.